A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...

Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine ... agreed to reduce the price of the product by 65% ...

The price reduction is being enabled by cutting ... a basal insulin that is biosimilar to and interchangeable with Lantus (insulin glargine) injection. Priced at $92 per five pack of KwikPens ...

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

The city school system alleges that drug manufacturers raised the price of insulin to win the business of pharmacy benefits managers — intermediary companies that negotiate prices between ...

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...